UniProt ID | LCP2_HUMAN | |
---|---|---|
UniProt AC | Q13094 | |
Protein Name | Lymphocyte cytosolic protein 2 | |
Gene Name | LCP2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 533 | |
Subcellular Localization | Cytoplasm . | |
Protein Description | Involved in T-cell antigen receptor mediated signaling.. | |
Protein Sequence | MALRNVPFRSEVLGWDPDSLADYFKKLNYKDCEKAVKKYHIDGARFLNLTENDIQKFPKLRVPILSKLSQEINKNEERRSIFTRKPQVPRFPEETESHEEDNGGWSSFEEDDYESPNDDQDGEDDGDYESPNEEEEAPVEDDADYEPPPSNDEEALQNSILPAKPFPNSNSMYIDRPPSGKTPQQPPVPPQRPMAALPPPPAGRNHSPLPPPQTNHEEPSRSRNHKTAKLPAPSIDRSTKPPLDRSLAPFDREPFTLGKKPPFSDKPSIPAGRSLGEHLPKIQKPPLPPTTERHERSSPLPGKKPPVPKHGWGPDRRENDEDDVHQRPLPQPALLPMSSNTFPSRSTKPSPMNPLPSSHMPGAFSESNSSFPQSASLPPYFSQGPSNRPPIRAEGRNFPLPLPNKPRPPSPAEEENSLNEEWYVSYITRPEAEAALRKINQDGTFLVRDSSKKTTTNPYVLMVLYKDKVYNIQIRYQKESQVYLLGTGLRGKEDFLSVSDIIDYFRKMPLLLIDGKNRGSRYQCTLTHAAGYP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
23 | Phosphorylation | DPDSLADYFKKLNYK CHHHHHHHHHHCCHH | 16.22 | 21082442 | |
29 | Phosphorylation | DYFKKLNYKDCEKAV HHHHHCCHHHHHHHH | 20.74 | - | |
30 | Ubiquitination | YFKKLNYKDCEKAVK HHHHCCHHHHHHHHH | 55.62 | - | |
39 | Phosphorylation | CEKAVKKYHIDGARF HHHHHHHHCCCHHHH | 9.78 | - | |
59 | Ubiquitination | NDIQKFPKLRVPILS HHHHHCCCCHHHHHH | 52.65 | 24816145 | |
80 | Phosphorylation | NKNEERRSIFTRKPQ HCCHHHHHHHHCCCC | 28.42 | 30576142 | |
106 | Phosphorylation | EEDNGGWSSFEEDDY CCCCCCCCCCCCCCC | 28.55 | - | |
107 | Phosphorylation | EDNGGWSSFEEDDYE CCCCCCCCCCCCCCC | 30.12 | - | |
113 | Phosphorylation | SSFEEDDYESPNDDQ CCCCCCCCCCCCCCC | 30.54 | 17148460 | |
128 | Phosphorylation | DGEDDGDYESPNEEE CCCCCCCCCCCCCCC | 24.68 | 17148460 | |
130 | Phosphorylation | EDDGDYESPNEEEEA CCCCCCCCCCCCCCC | 27.14 | 17353368 | |
145 | Phosphorylation | PVEDDADYEPPPSND CCCCCCCCCCCCCCC | 31.86 | 17148460 | |
169 | Phosphorylation | PAKPFPNSNSMYIDR CCCCCCCCCCCEECC | 30.44 | - | |
171 | Phosphorylation | KPFPNSNSMYIDRPP CCCCCCCCCEECCCC | 16.88 | - | |
173 | Phosphorylation | FPNSNSMYIDRPPSG CCCCCCCEECCCCCC | 10.25 | 16094384 | |
207 | Phosphorylation | PPAGRNHSPLPPPQT CCCCCCCCCCCCCCC | 31.51 | 23401153 | |
214 | Phosphorylation | SPLPPPQTNHEEPSR CCCCCCCCCCCCCCC | 44.29 | 26074081 | |
220 | Phosphorylation | QTNHEEPSRSRNHKT CCCCCCCCCCCCCCC | 46.28 | 26074081 | |
222 | Phosphorylation | NHEEPSRSRNHKTAK CCCCCCCCCCCCCCC | 41.60 | - | |
227 | Phosphorylation | SRSRNHKTAKLPAPS CCCCCCCCCCCCCCC | 22.82 | - | |
229 | Acetylation | SRNHKTAKLPAPSID CCCCCCCCCCCCCCC | 61.30 | 25953088 | |
234 | Phosphorylation | TAKLPAPSIDRSTKP CCCCCCCCCCCCCCC | 38.95 | 21949786 | |
240 | Ubiquitination | PSIDRSTKPPLDRSL CCCCCCCCCCCCCCC | 45.98 | 24816145 | |
246 | Phosphorylation | TKPPLDRSLAPFDRE CCCCCCCCCCCCCCC | 28.66 | - | |
256 | Phosphorylation | PFDREPFTLGKKPPF CCCCCCCCCCCCCCC | 45.37 | 28060719 | |
260 | Acetylation | EPFTLGKKPPFSDKP CCCCCCCCCCCCCCC | 57.00 | 25953088 | |
260 | Ubiquitination | EPFTLGKKPPFSDKP CCCCCCCCCCCCCCC | 57.00 | - | |
264 | Phosphorylation | LGKKPPFSDKPSIPA CCCCCCCCCCCCCCC | 50.96 | - | |
268 | Phosphorylation | PPFSDKPSIPAGRSL CCCCCCCCCCCCCCH | 47.12 | - | |
273 | Methylation | KPSIPAGRSLGEHLP CCCCCCCCCHHHCCC | 30.71 | 115386307 | |
274 | Phosphorylation | PSIPAGRSLGEHLPK CCCCCCCCHHHCCCC | 39.55 | - | |
297 | Phosphorylation | TTERHERSSPLPGKK CCCCCCCCCCCCCCC | 33.07 | 26657352 | |
298 | Phosphorylation | TERHERSSPLPGKKP CCCCCCCCCCCCCCC | 36.36 | 23401153 | |
338 | Phosphorylation | QPALLPMSSNTFPSR CCCEEECCCCCCCCC | 20.63 | 30108239 | |
339 | Phosphorylation | PALLPMSSNTFPSRS CCEEECCCCCCCCCC | 33.37 | 30108239 | |
341 | Phosphorylation | LLPMSSNTFPSRSTK EEECCCCCCCCCCCC | 38.58 | 28787133 | |
344 | Phosphorylation | MSSNTFPSRSTKPSP CCCCCCCCCCCCCCC | 34.37 | 30108239 | |
367 | Phosphorylation | MPGAFSESNSSFPQS CCCCCCCCCCCCCCC | 40.59 | 26074081 | |
369 | Phosphorylation | GAFSESNSSFPQSAS CCCCCCCCCCCCCCC | 42.51 | 26074081 | |
370 | Phosphorylation | AFSESNSSFPQSASL CCCCCCCCCCCCCCC | 45.24 | 26074081 | |
374 | Phosphorylation | SNSSFPQSASLPPYF CCCCCCCCCCCCCCC | 21.77 | 26074081 | |
376 | Phosphorylation | SSFPQSASLPPYFSQ CCCCCCCCCCCCCCC | 46.81 | 26074081 | |
380 | Phosphorylation | QSASLPPYFSQGPSN CCCCCCCCCCCCCCC | 17.58 | 26074081 | |
382 | Phosphorylation | ASLPPYFSQGPSNRP CCCCCCCCCCCCCCC | 28.52 | 26074081 | |
386 | Phosphorylation | PYFSQGPSNRPPIRA CCCCCCCCCCCCCCC | 52.90 | 26074081 | |
392 | Methylation | PSNRPPIRAEGRNFP CCCCCCCCCCCCCCC | 32.15 | 115386315 | |
410 | Phosphorylation | PNKPRPPSPAEEENS CCCCCCCCCHHHCCC | 39.15 | 28348404 | |
417 | Phosphorylation | SPAEEENSLNEEWYV CCHHHCCCCCCCEEE | 35.53 | 28464451 | |
423 | Phosphorylation | NSLNEEWYVSYITRP CCCCCCEEEEEECCH | 5.25 | 8702662 | |
425 | Phosphorylation | LNEEWYVSYITRPEA CCCCEEEEEECCHHH | 8.63 | - | |
426 | Phosphorylation | NEEWYVSYITRPEAE CCCEEEEEECCHHHH | 9.03 | 8702662 | |
428 | Phosphorylation | EWYVSYITRPEAEAA CEEEEEECCHHHHHH | 31.75 | - | |
438 | Ubiquitination | EAEAALRKINQDGTF HHHHHHHHHCCCCCE | 47.03 | 29967540 | |
454 | Phosphorylation | VRDSSKKTTTNPYVL EECCCCCCCCCCEEE | 42.46 | 25907765 | |
455 | Phosphorylation | RDSSKKTTTNPYVLM ECCCCCCCCCCEEEE | 33.19 | 25907765 | |
456 | Phosphorylation | DSSKKTTTNPYVLMV CCCCCCCCCCEEEEE | 39.15 | 25907765 | |
459 | Phosphorylation | KKTTTNPYVLMVLYK CCCCCCCEEEEEEEC | 14.32 | 25907765 | |
465 | Phosphorylation | PYVLMVLYKDKVYNI CEEEEEEECCCEEEE | 13.01 | 25907765 | |
470 | Phosphorylation | VLYKDKVYNIQIRYQ EEECCCEEEEEEEEE | 16.58 | - | |
476 | Phosphorylation | VYNIQIRYQKESQVY EEEEEEEEECCCEEE | 26.09 | - | |
483 | Phosphorylation | YQKESQVYLLGTGLR EECCCEEEEECCCCC | 6.64 | - | |
492 | Ubiquitination | LGTGLRGKEDFLSVS ECCCCCCCCCCCCHH | 47.91 | 29967540 | |
507 | Ubiquitination | DIIDYFRKMPLLLID HHHHHHHCCCEEEEC | 34.66 | 24816145 | |
516 | Ubiquitination | PLLLIDGKNRGSRYQ CEEEECCCCCCCCCE | 39.46 | 29967540 | |
522 | Phosphorylation | GKNRGSRYQCTLTHA CCCCCCCCEEEEECC | 15.05 | - | |
532 | Phosphorylation | TLTHAAGYP------ EEECCCCCC------ | 10.88 | 25839225 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
113 | Y | Phosphorylation | Kinase | SYK | P43405 | PSP |
113 | Y | Phosphorylation | Kinase | LCK | P06239 | PSP |
113 | Y | Phosphorylation | Kinase | SYK | Q15046 | PhosphoELM |
113 | Y | Phosphorylation | Kinase | ZAP70 | P43403 | PSP |
128 | Y | Phosphorylation | Kinase | SYK | P43405 | PSP |
128 | Y | Phosphorylation | Kinase | LCK | P06239 | PSP |
128 | Y | Phosphorylation | Kinase | SYK | Q15046 | PhosphoELM |
128 | Y | Phosphorylation | Kinase | ZAP70 | P43403 | PSP |
145 | Y | Phosphorylation | Kinase | LCK | P06239 | PSP |
145 | Y | Phosphorylation | Kinase | TXK | P42681 | PhosphoELM |
145 | Y | Phosphorylation | Kinase | ZAP70 | P43403 | PSP |
173 | Y | Phosphorylation | Kinase | ITK | Q08881 | PSP |
376 | S | Phosphorylation | Kinase | MAP4K1 | Q92918 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LCP2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LCP2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207, AND MASSSPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207, AND MASSSPECTROMETRY. | |
"Quantitative phosphoproteome analysis using a dendrimer conjugationchemistry and tandem mass spectrometry."; Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J.,Bodenmiller B., Watts J.D., Hood L., Aebersold R.; Nat. Methods 2:591-598(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-173 AND SER-207, ANDMASS SPECTROMETRY. | |
"Robust phosphoproteomic profiling of tyrosine phosphorylation sitesfrom human T cells using immobilized metal affinity chromatography andtandem mass spectrometry."; Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,Peters E.C.; Anal. Chem. 76:2763-2772(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-207, AND MASSSPECTROMETRY. |